Insider Trading activities of Entasis Therapeutics Holdings Inc. (ETTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Entasis Therapeutics Holdings Inc. (ETTX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Entasis Therapeutics Holdings Inc. since year 2005. Table 2 shows the detailed insider transactions of Entasis Therapeutics Holdings Inc. since 2005. The reporting company's ticker symbol is ETTX. The reporting company's CIK number is 1724344.
The total value of stock buying since 2005 is $64,061,640.
The total value of stock sales since 2005 is $250,000.
The total value of stock option exercises since 2005 is $75,432.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Entasis Therapeutics Holdings Inc. (ETTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-01 0 $0 50,000 $250,000 0 $0
2018-12 0 $0 0 $0 22,024 $75,432
2018-09 4,270,776 $64,061,640 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Entasis Therapeutics Holdings Inc. insiders (ETTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-01-09 Heron Patrick J (10% Owner) Sale 50,000 5.00 250,000
2018-12-21 Tommasi Ruben (Chief Scientific Officer) Option Ex 22,024 3.42 75,432
2018-09-28 Pivotal Bioventure Partners Fund I U.g.p., Ltd (10% Owner) Buy 337,724 15.00 5,065,860
2018-09-28 Fhm Life Sciences Viii, L.p. (10% Owner) Buy 375,887 15.00 5,638,305
2018-09-28 Preston Heather (Director) Buy 337,724 15.00 5,065,860
2018-09-28 Novo Holdings A/s (10% Owner) Buy 1,089,835 15.00 16,347,525
2018-09-28 Topper James N (Director) Buy 375,887 15.00 5,638,305
2018-09-28 Wheeler Kurt (10% Owner) Buy 453,395 15.00 6,800,925
2018-09-28 Galakatos Nicholas (Director) Buy 453,395 15.00 6,800,925
2018-09-28 Powell Michael (10% Owner) Buy 337,724 15.00 5,065,860
2018-09-28 Coulter James G Buy 262,539 15.00 3,938,085
2018-09-28 Astrazeneca Ab (10% Owner) Buy 246,666 15.00 3,699,990

Insider trading activities including stock purchases, stock sales, and option exercises of ETTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Entasis Therapeutics Holdings Inc. (symbol ETTX, CIK number 1724344) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month